ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.10 Cr | - | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ORCHID PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.10 Cr |
| Mar2024 | - |
| Mar2023 | ₹3.23 Cr |
| Mar2022 | ₹3.23 Cr |
| Mar2021 | ₹3.23 Cr |
How is Deferred Tax Assets / Liabilities of ORCHID PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.10 Cr | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹3.23 Cr | 0.00 | |
| Mar2022 | ₹3.23 Cr | 0.00 | |
| Mar2021 | ₹3.23 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,938.1 Cr | 11.7% | 35.3% | 1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 11.7% |
35.3% |
1% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses